N-acetylcysteine enhances endothelium-dependent vasorelaxation in the isolated rat mesenteric artery

Annals of Emergency Medicine

Volumn 32, Issue 4, 1998, Pages 405-410

  Lopez, B L ^a   Snyder, J W ^a   Birebaum, D S ^a   Ma, X L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; NITRIC OXIDE; PARACETAMOL;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG OVERDOSE; ENDOTHELIUM CELL; LIVER BLOOD FLOW; LIVER PROTECTION; LIVER TOXICITY; MALE; MESENTERIC ARTERY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031732015     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-0644(98)70167-2     Document Type: Article

References (31)

1. R Esterline SD Ray Reversible and irreversible inhibition of hepatic mitochondrial respiration of acetaminophen and its toxic metabolite, N -acetyl- p -benzoquinoneimine (NAPQI) Biochem Pharmacol 38 1989 2387 2390
2. BH Lauterburg GB Corcoran JR Mitchell Mechanism of action of N -acetylcysteine in the protection against the hepatotoxicity in rats in vivo J Clin Invest 71 1983 980 991
3. PM Harrison R Keays GP Bray Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine Lancet 335 1990 1572 1575
4. R Keays PM Harrison JA Wendon Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial Br Med J 303 1991 1026 1029
5. PM Harrison JA Wendon AES Gimson Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure N Engl J Med 324 1991 1852 1857
6. JM Rappeport HF Bunn Bone marrow failure: Aplastic anemia and other primary bone marrow disorders E Braunwald KJ Isselbacher RG Petersdorf Harrison’s Principles of Internal Medicine 1994 : McGraw-Hill New York 1754 1756
7. LJ Ignarro GM Buga KS Wood Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc Natl Acad Sci U S A 84 1987 9265 9269
8. GM Rubanyi PM Vanhoute Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor Am J Physiol 250 1986 H822 H827
9. JB Hibbs Jr Z Vavrin RR Taintor Nitric oxide: A cytotoxic-activated macrophage effector molecule Biochem Biophys Res Commun 157 1988 87 94
10. 2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone Br J Pharmacol 101 1990 489 493
11. JH Chin S Azhar BB Hoffman Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins J Clin Invest 89 1992 10 18
12. JZ Sun H Kaur B Halliwell Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo Circ Res 73 1993 534 549
13. TL Yue PJ McKenna JL Gu Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells Hypertension 22 1993 922 928
14. S Moncada RMJ Palmer RJ Gryglewski Mechanism of action of some inhibitors of endothelium-derived relaxing factor Proc Natl Acad Sci U S A 83 1986 9164 9168
15. J Stamler ME Mandelsohn P Amarante N -acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor Circ Res 65 1989 789 795
16. RF Furchgott JV Zawadski The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
17. S Moncada RMJ Palmer EA Higgs The discovery of nitric oxide as the endogenous nitrovasodilator Hypertension 12 1988 365 372
18. S Moncada MW Radomski RMJ Palmer Endothelium derived relaxing factor: Identification as nitric oxide and role in the control of vascular tone and platelet function Biochem Pharmacol 37 1988 2495 2501
19. JR Vane EE Anggard RM Botting Regulatory functions of the vascular endothelium N Engl J Med 323 1990 27 36
20. A Calver J Collier P Vallance Nitric oxide and cardiovascular control Exp Physiol 78 1993 303 326
21. XL Ma BL Lopez TA Christopher Exogenous nitric oxide inhibits basal NO release from vascular endothelium in vitro and in vivo Am J Physiol 271 1996 H2045 H2051
22. TA Christopher BL Lopez XL Ma Effects of a hydroxylated metabolite of the β-adrenoreceptor antagonist, carvedilol, on post-ischemic splanchnic tissue injury Br J Pharmacol 123 1998 292 298
23. A Meister Glutathione metabolism Methods Enzymol 251 1995 3 7
24. RC Scaduto Jr Glutathione in ischemia and reperfusion-induced tissue injury J Vina Glutathione: Metabolism and Physiologic Functions . 1990 : CRC Press Boca Raton
25. JR Mitchell DJ Jollow WZ Potter Acetaminophen induced hepatic necrosis: Protective role of glutathione J Pharmacol Exp Ther 187 1973 211 217
26. MW Radomski RMJ Palmer S Moncada Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium Lancet 2 1987 1057 1058
27. M Shiraishi T Kusano Y Ikeda Protection against hepatic ischemia/reperfusion injury by exogenous L -arginine Transplant Proc 28 1996 1887 1888
28. H Kobayashi T Nonami T Kurokawa Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver J Surg Res 56 1995 772 779
29. Y Wang WR Matthews DM Guido Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia Shock 4 1995 282 288
30. JS Stamler S -Nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups Curr Top Microbiol Immunol 196 1995 19 36
31. DR Arnelle JS Stamler NO+, NO, and NO– donation by s -nitrosothiols: Implications for regulation of physiological functions by s-nitrosylation and acceleration of disulfide formation Arch Biochem Biophys 318 1995 279 285